herapeutic based
laser systems, disposable laser probes and delivery devices to treat eye
diseases in ophthalmology and skin disorders in the aesthetics market.
IRIDEX products are sold in the United States through a direct sales force
and internationally through a combination of a direct sales force and a
network of approximately 100 independent distributors into 107 countries.
For further information, visit the Company's website at
http://www.iridex.com.
Safe Harbor Statement
This announcement contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended and
Section 21E of the Securities Act of 1934, as amended, relating to the
Company's financial stability. Please see a detailed description of these
and other risks contained in our Annual Report on Form 10-K for the fiscal
year ended December 29, 2007 and our Quarterly Report on Form 10-Q for the
third quarter ended September 27, 2008 filed with the Securities and
Exchange Commission. Forward- looking statements contained in this
announcement are made as of this date and will not be updated.
IRIDEX Corporation
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(unaudited)
Three Months Ended Nine Months Ended
September September September September
27, 29, 27, 29,
2008 2007 2008 2007
Revenues $11,987 $13,575 $36,383 $41,390
Cost of revenues 6,997 7,390 21,257 23,412
Gross profit 4,990 6,185 15,126 17,978
Operating expenses:
Research and develo
'/>"/>
SOURCE IRIDEX Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine news :1.
IRIDEX Announces Third Quarter 2008 Conference Call and Release Date2.
IRIDEX Reports First Quarter 2008 Financial Results3.
IRIDEX Announces First Quarter 2008 Conference Call and Release Date4.
IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results5.
IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date6.
IRIDEX Reports Third Quarter Financial Results7.
IRIDEX Announces Third Quarter 2007 Conference Call and Release Date8.
Theodore A. Boutacoff Appointed President & CEO of IRIDEX9.
James B. Hawkins Appointed to IRIDEX Board of Directors10.
IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor11.
William Moore Appointed to IRIDEX Board of Directors